Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  DNA-PK/TOR kinase inhibitor CC-115
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
Abemaciclib, DNA-PK/TOR Kinase Inhibitor CC-115, or Neratinib in Treating Patients with Brain Tumors after Biomarker Screening
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 16-443, NCI-2017-00433, NCT02977780
Enzalutamide and DNA-PK/TOR Kinase Inhibitor CC-115 in Treating Patients with Metastatic Castration-Resistant Prostate Cancer
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 16-074, NCI-2016-01114, NCT02833883
Start Over